跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
netupitant + palonosetron
首页
药物
netupitant + palonosetron
netupitant + palonosetron
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
LIQUID ORAL FORMULATIONS OF NETUPITANT AND PALONOSETRON
EP 4775201 A1
申请人: HELSINN HEALTHCARE SA
优先权: 2023
CN
EP
US
WO
6 件公开
Stable liquid compositions of netupitant and palonosetron
US 12097197 B2
申请人: SLAYBACK PHARMA LLC
优先权: 2021
US
4 件公开
FIXED DOSE COMBINATION COMPRISING NETUPITANT AND PALONOSETRON
EP 4633612 A1
申请人: TIEFENBACHER ALFRED E GMBH & CO KG
优先权: 2022
CN
EP
WO
3 件公开
EP 4385500 B1
申请人: TIEFENBACHER ALFRED E GMBH & CO KG
优先权: 2022
EP
Therapeutic combinations of netupitant and palonosetron
US 9358228 B2
申请人: HELSINN HEALTHCARE SA
优先权: 2011
CN
US
3 件公开
ANTIOXIDANT-FREE FIXED DOSE COMBINATION OF NETUPITANT AND PALONOSETRON
EP 4633608 A1
申请人: TIEFENBACHER ALFRED E GMBH & CO KG
优先权: 2022
EP
WO
2 件公开
EP 4385497 A1
申请人: TIEFENBACHER ALFRED E GMBH & CO KG
优先权: 2022
EP
Compositions for treating centrally mediated nausea and vomiting
CN 104856998 A
申请人: HELSINN HEALTHCARE SA
优先权: 2009
CN
2 件公开
Compositions and methods for treating centrally mediated nausea and vomiting
US 8623826 B2
申请人: TRENTO FABIO
优先权: 2011
US
Netupitant-cyclodextrin inclusion compound, compounded combination preparation, preparation method and use thereof
CN 108853010 A
申请人: HE LONG
优先权: 2017
CN
药物
反馈